Fractyl Health, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.fractyl.com
Clinical Trials
7
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
- Conditions
- Weight Change TrajectoryWeight Change, BodyObesity
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Fractyl Health Inc.
- Target Recruit Count
- 315
- Registration Number
- NCT06484114
- Locations
- 🇺🇸
Helios Clinical Research, Phoenix, Arizona, United States
🇺🇸Honor Health, Scottsdale, Arizona, United States
🇺🇸Hoag Hospital, Newport Beach, California, United States
A Prospective Study to Evaluate Revita DMR Post Market Pilot Clinical Follow-Up Registry in Patient with Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2024-02-13
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Fractyl Health Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06256497
- Locations
- 🇩🇪
Westdeutsches Diabetes und Gesundheitszentrum, Duesseldorf, Germany
Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Fractyl Health Inc.
- Target Recruit Count
- 320
- Registration Number
- NCT04419779
- Locations
- 🇺🇸
Helios CR, Inc, Phoenix, Arizona, United States
🇺🇸HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic Arizona, Scottsdale, Arizona, United States
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Fractyl Health Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03653091
- Locations
- 🇺🇸
Florida Hospital / TRANSLATIONAL RESEARCH INSTITUTE FOR METABOLISM AND DIABETES (TRI), Orlando, Florida, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)
- Conditions
- Diabetes Mellitus, Type 2Noninsulin-Dependent Diabetes Mellitus
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Fractyl Health Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT02879383
- Locations
- 🇧🇪
Hopital Erasme, Brussels, Belgium
🇧🇪UZ Leuven, Leuven, Belgium
🇧🇷Hospital das Clinicas da Faculdade de medicina da Universidade de São Paulo, Sao Paulo, Brazil
- Prev
- 1
- 2
- Next